ASPIRE BIOPHARMA HOLDINGS, INC. Retained Earnings
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) had Retained Earnings of -$31.75 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$31.75M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$30.48M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$27.26M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$22.55M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$31.75M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$30.48M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$27.26M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$22.55M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$20.70M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | -$18.72M 10-Q/A · filed 2025-08-13 | |
| 2024-12-31 | -$2.78M S-1/A · filed 2026-04-10 | -$24.37M 10-K · filed 2025-04-07 |
| 2024-09-30 | -$15.38M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$14.76M 10-Q · filed 2024-08-16 | |
| 2024-03-31 | -$13.99M 10-Q · filed 2024-06-05 | |
| 2023-12-31 | -$11.29M 10-K · filed 2025-04-07 | |
| 2023-09-30 | -$10.88M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | -$10.55M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | -$10.26M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$9.94M 10-K · filed 2024-03-11 | |
| 2022-09-30 | -$9.62M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$9.37M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$9.05M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$25.48K 10-K · filed 2023-03-21 | -$1.19K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |